No study indicated the cut-off value of circulating basophil count in gastric cancer; thus, this study aimed to establish an appropriate cut-off value (< 26/µl) as the derivation cohort. We assessed the clinicopathological significance of preoperative circulating basophil count in surgically treated gastric cancer. Additionally, we revealed that low basophil count was associated with tumor progression. The low basophil count was an independent risk factor for poor overall survival. This study is the first to reveal an association between preoperative circulating basophil count and prognosis in surgically treated gastric cancer.
Other similar studies, indicated cut-off values for circulating basophil count at 25/µl (area under the curve = 0.669) in colorectal cancer [13] and 20/µl (area under the curve = 0.7208) in unresectable gastric cancer [9] based on receiver operating characteristic curves. This value was similar to the cut-off value set in our present study, so the cut-off value might be reasonable.
Peripheral blood cell count studies revealed low lymphocyte count [4] and high neutrophil count [17] as risk factors for poor prognosis in gastric cancer. Since basophils are negatively correlated with neutrophils, it is natural that low basophil counts are a poor prognostic factor. Our study revealed that low lymphocyte count, high neutrophil count, and low basophil count were independent poor prognostic factors. A significant correlation between low basophil, low lymphocyte, and neutrophil count was observed, which may reflect decreased hematopoietic function mainly due to aging. A significant correlation between low basophil count and high CRP level was observed because differentiation into neutrophils is prioritized during infiltration that causes high CRP levels, such as inflammation or infection.
The immunohistochemical analysis of previous reports revealed that a large number of basophils infiltrating the tumor was a poor prognostic factor in gastric cancer [9, 18]. Furthermore, it has been reported that there is a positive correlation between the infiltration of basophils into the tumor and the infiltration of M2 macrophages into the tumor in gastric cancer. Macrophages are known to promote tumor angiogenesis and distant metastasis [19, 20], suggesting that basophils may also be immunologically involved in the tumor microenvironment in gastric cancer. There are only limited reports on the relationship between the number of basophils in peripheral blood and the number of basophils infiltrating into the tumor, and it is not yet fully understood. Chronic urticaria is a typical disease in which the number of basophils in the peripheral blood decreases. In patients with chronic urticaria, the number of basophils in the peripheral blood decreases as basophils are recruited to the skin, which is the main site of inflammation. [21] Considering the biological response of patients with chronic urticaria, gastric cancer patients may also similarly decrease the number of circulating basophils due to an increase in the number of basophils infiltrating the tumor. Regarding the prognosis in unresectable gastric cancer who were treated with immunotherapy, the high basophil group demonstrated a worse prognosis than the low basophil group [9]. This contradicts our study results probably because the research participants were limited to recurrence and distant metastasis cases [9]. The prognosis of the high and low basophil count groups was very similar in stage I. This indicates that the low basophil counts did not have any effects on the other cause of death in stage I. The absence of a statistically significant difference in stage III/IV was due to the insufficient number of cases.
This study has some limitations. First, this is a retrospective single-center study. Second, this study did not investigate the patient’s history of immune diseases, vulnerabilities including bone marrow function, allergies, or use of immune-related drugs, including anti-allergy drugs and/or steroids. Third, this study included long periods of patients; thus, various adjuvant chemotherapy and systematic therapy after recurrence influenced the prognosis. The present study was a derivation cohort to fix the appropriate cut-off value of circulating basophil count. Further evaluation cohort is warranted to ensure the impact of circulating basophil count. Therefore, further multi-institutional studies are required to assess the effect of low circulating basophil counts on the survivals in patients with gastric cancer postoperatively.
In conclusion, low basophil count was significantly associated with high neutrophil count and high CRP level, but low basophil count was an independent poor prognostic factor in patients with gastric cancer. Thus, preoperative circulating basophil count assessment may be useful for predicting the postoperative survival of patients with gastric cancer.